PetVivo raises $1.25M in private placement of units at $0.90/unit

PetVivo Holdings, Inc.

Sold 1,386,469 units to 13 accredited investors at $0.90 per unit.
Each unit includes one restricted share and one warrant exercisable at $1.50 until Feb 1, 2027.
Proceeds to be used for commercialization of Spryng™ with OsteoCushion™ Technology, clinical trials, and working capital.
Warrants are immediately exercisable with no cashless exercise rights.
Securities are restricted under Rule 144; no registration rights.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.